Neoadjuvant Atezolizumab in Localized Bladder Cancer

NCT02451423 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Transitional Cell

Interventions

DRUG: Atezolizumab

Sponsor

Lawrence Fong

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]